These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 25864869)
41. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay. Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290 [TBL] [Abstract][Full Text] [Related]
42. Tight binding inhibitors of N-acyl amino sugar and N-acyl amino acid deacetylases. Xu C; Hall R; Cummings J; Raushel FM J Am Chem Soc; 2006 Apr; 128(13):4244-5. PubMed ID: 16568996 [TBL] [Abstract][Full Text] [Related]
43. Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity. Li JR; Li DD; Wang RR; Sun J; Dong JJ; Du QR; Fang F; Zhang WM; Zhu HL Eur J Med Chem; 2014 Mar; 75():438-47. PubMed ID: 24561667 [TBL] [Abstract][Full Text] [Related]
44. Phenylimidazole derivatives as specific inhibitors of bacterial enoyl-acyl carrier protein reductase FabK. Ozawa T; Kitagawa H; Yamamoto Y; Takahata S; Iida M; Osaki Y; Yamada K Bioorg Med Chem; 2007 Dec; 15(23):7325-36. PubMed ID: 17892940 [TBL] [Abstract][Full Text] [Related]
45. Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor. Gross M; Clements J; Beckett RP; Thomas W; Taylor S; Lofland D; Ramanathan-Girish S; Garcia M; Difuntorum S; Hoch U; Chen H; Johnson KW J Antimicrob Chemother; 2004 Mar; 53(3):487-93. PubMed ID: 14963065 [TBL] [Abstract][Full Text] [Related]
46. Inhibition and structure-activity studies of methionine hydroxamic acid derivatives with bacterial peptide deformylase. Grant SK; Green BG; Kozarich JW Bioorg Chem; 2001 Aug; 29(4):211-22. PubMed ID: 16256693 [TBL] [Abstract][Full Text] [Related]
47. Inhibitors of bacterial N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) and demonstration of in vitro antimicrobial activity. Gillner D; Armoush N; Holz RC; Becker DP Bioorg Med Chem Lett; 2009 Nov; 19(22):6350-2. PubMed ID: 19822427 [TBL] [Abstract][Full Text] [Related]
48. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model. Odenholt I; Cars O J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293 [TBL] [Abstract][Full Text] [Related]
49. MurD enzymes from different bacteria: evaluation of inhibitors. Barreteau H; Sosič I; Turk S; Humljan J; Tomašić T; Zidar N; Hervé M; Boniface A; Peterlin-Mašič L; Kikelj D; Mengin-Lecreulx D; Gobec S; Blanot D Biochem Pharmacol; 2012 Sep; 84(5):625-32. PubMed ID: 22705647 [TBL] [Abstract][Full Text] [Related]
50. Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis. Whittington DA; Rusche KM; Shin H; Fierke CA; Christianson DW Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8146-50. PubMed ID: 12819349 [TBL] [Abstract][Full Text] [Related]
51. Water-soluble substrates of the peptidoglycan-modifying enzyme O-acetylpeptidoglycan esterase (Ape1) from Neisseria gonorrheae. Hadi T; Pfeffer JM; Clarke AJ; Tanner ME J Org Chem; 2011 Feb; 76(4):1118-25. PubMed ID: 21244065 [TBL] [Abstract][Full Text] [Related]
52. Identification of an inhibitor of the MurC enzyme, which catalyzes an essential step in the peptidoglycan precursor synthesis pathway. Zawadzke LE; Norcia M; Desbonnet CR; Wang H; Freeman-Cook K; Dougherty TJ Assay Drug Dev Technol; 2008 Feb; 6(1):95-103. PubMed ID: 18315498 [TBL] [Abstract][Full Text] [Related]
53. Inhibitors of Streptococcus pneumoniae surface endonuclease EndA discovered by high-throughput screening using a PicoGreen fluorescence assay. Peterson EJ; Kireev D; Moon AF; Midon M; Janzen WP; Pingoud A; Pedersen LC; Singleton SF J Biomol Screen; 2013 Mar; 18(3):247-57. PubMed ID: 23015019 [TBL] [Abstract][Full Text] [Related]
54. Inhibitors of the bacterial cell wall biosynthesis enzyme MurD. Gegnas LD; Waddell ST; Chabin RM; Reddy S; Wong KK Bioorg Med Chem Lett; 1998 Jul; 8(13):1643-8. PubMed ID: 9873406 [TBL] [Abstract][Full Text] [Related]
55. The TPR domain of PgaA is a multifunctional scaffold that binds PNAG and modulates PgaB-dependent polymer processing. Pfoh R; Subramanian AS; Huang J; Little DJ; Forman A; DiFrancesco BR; Balouchestani-Asli N; Kitova EN; Klassen JS; Pomès R; Nitz M; Howell PL PLoS Pathog; 2022 Aug; 18(8):e1010750. PubMed ID: 35930610 [TBL] [Abstract][Full Text] [Related]
56. A Colorimetric Assay to Enable High-Throughput Identification of Biofilm Exopolysaccharide-Hydrolyzing Enzymes. Wang S; Breslawec AP; Li C; Poulin MB Chemistry; 2020 Aug; 26(47):10719-10723. PubMed ID: 32589289 [TBL] [Abstract][Full Text] [Related]
57. Double iterative optimisation for metabolic network-based drug target identification. Song B; Sridhar P; Kahveci T; Ranka S Int J Data Min Bioinform; 2009; 3(2):124-44. PubMed ID: 19517985 [TBL] [Abstract][Full Text] [Related]
58. Detection of Enzymes, Viruses, and Bacteria Using Glucose Meters. Das A; Cui X; Chivukula V; Iyer SS Anal Chem; 2018 Oct; 90(19):11589-11598. PubMed ID: 30191710 [TBL] [Abstract][Full Text] [Related]
59. Histone de-acetylase inhibitors: a promising future for cancer treatment? Khan RS; Hameed H; Bhutta RA; Kazi AN; Riaz H Infect Agent Cancer; 2013 Mar; 8(1):10. PubMed ID: 23497649 [No Abstract] [Full Text] [Related]